Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) Net Margin (2016 - 2025)

Historic Net Margin for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to 136.3%.

  • HealthLynked's Net Margin rose 1469200.0% to 136.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 118.47%, marking a year-over-year increase of 385600.0%. This contributed to the annual value of 203.81% for FY2024, which is 1861300.0% down from last year.
  • According to the latest figures from Q3 2025, HealthLynked's Net Margin is 136.3%, which was up 1469200.0% from 73.5% recorded in Q2 2025.
  • HealthLynked's Net Margin's 5-year high stood at 172.95% during Q4 2021, with a 5-year trough of 443.32% in Q1 2021.
  • Over the past 5 years, HealthLynked's median Net Margin value was 107.31% (recorded in 2022), while the average stood at 110.83%.
  • Over the last 5 years, HealthLynked's Net Margin had its largest YoY gain of 3611500bps in 2022, and its largest YoY loss of -4831800bps in 2022.
  • HealthLynked's Net Margin (Quarter) stood at 172.95% in 2021, then crashed by -279bps to 310.23% in 2022, then soared by 55bps to 138.07% in 2023, then plummeted by -44bps to 198.76% in 2024, then soared by 31bps to 136.3% in 2025.
  • Its Net Margin stands at 136.3% for Q3 2025, versus 73.5% for Q2 2025 and 79.74% for Q1 2025.